Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V5SC
|
||||
Former ID |
DIB016644
|
||||
Drug Name |
Liproca Depot
|
||||
Synonyms |
Liproca; 2-hydroxyflutamide; 2-hydroxyflutamide implant (injectable, controlled release), Lidds
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 2 | [1] | ||
Company |
LIDDS AB
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
c1(c(ccc(c1)NC(=O)C(C)(C)O)[N+](=O)[O-])C(F)(F)F
|
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Antagonist | [2] | |
KEGG Pathway | Oocyte meiosis | ||||
Pathways in cancer | |||||
Prostate cancer | |||||
NetPath Pathway | EGFR1 Signaling Pathway | ||||
AndrogenReceptor Signaling Pathway | |||||
FSH Signaling Pathway | |||||
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
Reactome | Nuclear Receptor transcription pathway | ||||
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | |||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Integrated Pancreatic Cancer Pathway | |||||
Prostate Cancer | |||||
Integrated Breast Cancer Pathway | |||||
Nuclear Receptors | |||||
Androgen receptor signaling pathway | |||||
References | |||||
REF 1 | ClinicalTrials.gov (NCT02341404) A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer. U.S. National Institutes of Health. | ||||
REF 2 | Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T). J Steroid Biochem Mol Biol. 1992 Jun;42(5):547-54. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.